| Sara Hough Mitchell, LMSW | |
|
113 E 12th St, Eureka, KS 67045-1019 | |
| (620) 794-8935 | |
| Not Available |
| Full Name | Sara Hough Mitchell |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 113 E 12th St, Eureka, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275246431 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 7467 (Kansas) | Primary |
| 104100000X | Social Worker | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Sara Hough Mitchell, LMSW 119 Jones St, El Dorado, KS 67042-1469 Ph: (620) 794-8935 | Sara Hough Mitchell, LMSW 113 E 12th St, Eureka, KS 67045-1019 Ph: (620) 794-8935 |
News Archive
A study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and metabolism.
A burst aneurysm in the abdominal aorta-the largest blood vessel in the body- is a deadly condition. In fact, about half of these patients don't make it to the hospital in time. Those who do more often than not face open surgery to repair the blood vessel. This study finds that a minimally invasive interventional radiology treatment for ruptured aneurysms called endovascular aneurysm repair is safer than open surgical repair and is associated with lower mortality rates, say researchers Society of Interventional Radiology's 37th Annual Scientific Meeting in San Francisco, Calif.
In research led by a Saint Louis University investigator, molecular biologists have discovered a way to harness the enzyme thrombin's anti-blood clotting properties. The finding opens the door to new medications that will treat diseases related to thrombosis, the presence of blood clots in blood vessels, which is responsible for nearly a third of all deaths in the U.S.
Taking the first deep dive into how the immune system is behaving in patients with multisystem inflammatory syndrome in children (MIS-C), researchers at Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania have found that children with this condition have highly activated immune systems that, in many ways, are more similar to those of adults with severe COVID-19.
Vertex Pharmaceuticals Incorporated today announced that sustained virologic response (SVR) data from Study C208, which evaluated twice-daily dosing of Vertex's investigational hepatitis C virus (HCV) protease inhibitor telaprevir, will be presented in an oral presidential plenary session at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) taking place Oct. 30 – Nov. 3, 2009 in Boston.
› Verified 2 days ago